On December 19, 2019, Aspnes, Gary Erik; Bagley, Scott W.; Conn, Edward L.; Curto, John M.; Edmonds, David James; Flanagan, Mark E.; Futatsugi, Kentaro; Griffith, David A.; Huard, Kim; Limberakis, Chris; Mathiowetz, Alan M.; Piotrowski, David W.; Ruggeri, Roger B. published a patent.Electric Literature of 1255717-13-5 The title of the patent was GLP-1 receptor agonists and uses thereof. And the patent contained the following:
Provided herein are 6-carboxylic acids of benzimidazoles and 4-aza-, 5-aza-, and 7-aza- benzimidazoles as GLP-1R agonists, processes to make said compounds, and methods comprising administering said compounds to a mammal in need thereof. The experimental process involved the reaction of (1-Ethyl-1H-imidazol-5-yl)methanamine dihydrochloride(cas: 1255717-13-5).Electric Literature of 1255717-13-5
The Article related to glp1 receptor agonist benzimidazole preparation cardiometabolic disease, Pharmacology: Effects Of Cardiovascular, Hematologic, and Renal Drugs and other aspects.Electric Literature of 1255717-13-5
Referemce:
Imidazole – Wikipedia,
Imidazole | C3H4N2 – PubChem